lawsuit tirzepatide Zepbound [2026] A federal court in Delaware

Users with hepatic impairment Neither semaglutide nor tirzepatide requires dose adjustment for mild to moderate hepatic impairment

The most common symptoms are joint pain and stiffness, fatigue, and skin rashes (often a butterfly-shaped rash across the cheeks and nose)

Your provider may also recommend phentermine/topiramate if you have a history of GI problems, since GLP-1 medications can be accompanied with some nausea, vomiting, diarrhea, bloating, or constipation at first

Preclinical studies have also revealed that dual agonists of GLP-1R and glucose-dependent insulinotropic polypeptide receptor (GIPR) have synergistic anti-inflammatory and neuroprotective effects, suggesting the potential advantages of multitargeting strategies (Yuan et al., 2024)

In PCOS patients the addition of low-dose spironolactone induces a more marked reduction of clinical and biochemical hyperandrogenism than metformin alone